Summary Box: J&J Defends Insulin Pumps Amid Probe

Salon Staff
January 12, 2012 4:36AM (UTC)

FDA PROBE: The Food and Drug Administration tells Johnson & Johnson it could face fines over selling insulin pumps with faulty keypads and not promptly reporting serious injuries to diabetics using its OneTouch Ping and 2020 pumps.

COMPANY RESPONSE: J&J's Animas unit says the injured patients didn't follow pump directions and the keypads weren't a risk to people. It will soon respond to FDA's demand to correct violations.


QUALITY LAPSES: It's at least the seventh J&J business in the last 2 1/2 years to run into problems with the FDA or recall products with safety or quality issues.

Salon Staff

MORE FROM Salon Staff

Fearless journalism
in your inbox every day

Sign up for our free newsletter

• • •